NasdaqGS:HSICHealthcare
Henry Schein (HSIC): Evaluating Valuation in Light of Executive Departure and $750M Buyback Expansion
If you are holding or tracking Henry Schein (HSIC), there is more to watch than just the sales charts right now. The company grabbed headlines again as long-time executive James Breslawski stepped away from his Senior Advisor position just months after moving on from the President role. In addition, a fresh $750 million increase in the company’s share buyback authorization represents another headline-making move with the potential to shape investor sentiment and Henry Schein’s future...